Yasutaka Kimoto
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
High baseline CD317 expression on T cells predicts favorable anifrolumab response in systemic lupus erythematosus.
Journal: Frontiers in immunology
Published: November 28, 2025
A case of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with a challenging diagnosis due to the absence of typical skin manifestations.
Journal: Modern rheumatology case reports
Published: November 26, 2025
Effectiveness, Tolerability, and Safety of Mepolizumab Injection Spacing in Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: October 23, 2025
Elevated soluble CD226 in Takayasu arteritis is useful for differentiation from giant cell arteritis, disease activity assessment, and prognosis prediction.
Journal: Medicine
Published: June 23, 2025
Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study.
Journal: Arthritis research & therapy
Published: June 18, 2025
Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases.
Journal: Scandinavian journal of rheumatology
Published: April 02, 2024
No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study.
Journal: Rheumatology international
Published: February 02, 2024
Determination of the factors associated with antigen-specific CD4+ T-cell responses to BNT162b2 in patients with rheumatoid arthritis.
Journal: RMD open
Published: September 06, 2023
Recent advances in the treatment strategy for AAV improved outcomes with intensive GC tapering.
Journal: International journal of rheumatic diseases
Published: June 10, 2023
Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan.
Journal: Modern rheumatology
Published: May 01, 2023
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.
Journal: Rheumatology (Oxford, England)
Published: April 04, 2023
Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosus.
Journal: Rheumatology (Oxford, England)
Published: November 02, 2022
Last Updated: 09/26/2026